Competitive intelligence is the cornerstone of our business

We are CI scientists – A team of CI and technology professionals with more than three decades of collective consulting experience in the Pharmaceutical/Biotech industry

Seamless delivery experience catering to your time zones

Customer driven consulting…

Competitive Intelligence

When did the product/molecule complete its phase 3 trial?

How have the changes to the competitive market basket impacted your portfolio?

What is the potential geographical launch sequence of a new product?

Business Insights

How does the market landscape look like?

What are the estimated approval timelines for the selected NMEs?

Will the change in treatment guidelines impact market share?

Medical, Clinical & Regulatory

What are the changes in trial design, recruitment and data reporting in given geographies?

How has the major CRL impacted the competitor life cycle strategies?

What are the I-O biomarkers and assays being used to measure results of molecules?

Commercial, BD&L

With changing milestones and therapeutic armamentaria:

Who is playing where?

What is the intensity of competition?

Which MOAs/Drug class/assets should we look at?


Our offerings are built based on deep understanding of the needs of the pharma/biotech stakeholders

How we work


  • Our collective global pharma experience of more than 30 years goes across all functional areas of the Rx life cycle
  • Our data architects have CI expertise in multiple therapy areas
  • Our technology architects have domain expertise in building and maintaining products in complex environments


  • Data is seamlessly processed utilizing cutting edge technology
  • Web-enabled and mobile friendly therefore accessible on the go
  • Curated by client focused subject matter experts


Our bespoke analysis frameworks have been carefully built based on learnings from customers and stakeholders across therapeutic areas to ensure a holistic approach

  • All SOPs have in-built three-tiered quality control checks
  • We are live 24/7 to provide seamless global coverage
  • Our deep client engagement approach leads to insights driven analyses and outputs

Who we are

Sandhya Ramalingam PhD

Co-founder and CEO

Vivek Singh

Co-founder and COO

Sara Misch

Strategic Consultant – Business Development

We invite you to continue the conversation

Sandhya Ramalingam PhD

Vivek Singh

Sara Misch

34B, Dream Meadows, ITPL Road, Bangalore – 560037, INDIA


Sandhya Ramalingam, PhD

As Co-founder and CEO, Sandhya focuses on the strategic vision of the company. She brings two decades of client side and consulting experience to provide creative solutions. An astute leader and team builder, she brings a participative management philosophy which makes work a fun place.

Prior to founding CI Scientists, she was Vice President and Head of Delivery at Course 5i (Blueocean) where she managed all delivery and operations for the life sciences practice. In the past, she has led the Market insights group at IQVIA (IMS) and held global positions in the US (Novartis, J&J, Pfizer, MSD).

Sandhya has a PhD in molecular biology and a MS in computer sciences with several publications in peer reviewed journals. She works with non-profit organizations to spread the awareness of non-communicable diseases (Diabetes) using mHealth applications. She also loves to trek in the Himalayas.

Vivek Singh

As Co-founder and COO, Vivek is focused on engaging with clients to provide a seamless consulting experience. He has an excellent track record of client management and believes in the phrase “customer first”.

Prior to CI Scientists, he worked with Course 5i (Blueocean), Britannia Industries and GlaxoSmithKline Knowledge Centre (@WNS). In his previous roles, he has anchored and led several projects in competitive intelligence and forecasting across various therapy areas. His expertise spans the entire global product life cycle which helps bring in a holistic view to our solutions. He has also built and scaled up large cross-functional teams.

Vivek has an MBA in Marketing with a BS in Biotechnology. He is passionate about swimming and experimenting with different cuisines.

Sara Misch

As Vice President – Business Development, Sara is passionate about establishing rapport and building client partnerships. She brings clarity and a strategic perspective to achieve performance goals within complex markets, by identifying innovative analytic approaches.

Sara has over 20 years experience delivering pharma business and CI insights globally within large matrix organizations and across external alliances (BMS, Novartis, Pfizer, Schering-Plough, Merck). She has led CI initiatives and market research teams for global brands in oncology, neurology, immunology, and anti-infectives.
In her spare time Sara is a cycling and alpine skiing enthusiast, enjoys trail hikes with her family and dog, and plays competitive tennis on several teams.